How this UH pharmacologist tapped into humanities to improve health outcomes in her study. Graphic by Miguel Tovar/University of Houston

The humanities, encompassing language, literature, arts, and history, are often seen as separate from scientific research in universities.

However, they hold the potential to contribute to improved health outcomes by fostering empathy, understanding of cultural context, and enhancing human connections. Meghana Trivedi, an associate professor of Pharmacy Practice and Translational Research at the University of Houston, has embarked on a research project to explore this transformative potential.

Using media to improve medicine adherence

Trivedi, a pharmacologist focusing on developing new drugs for breast cancer treatment, noticed a common issue among breast cancer patients — non-adherence to medication instructions, particularly among minority patients with low socioeconomic status. This non-adherence increases the risk of recurrence and poses a significant national problem.

Trivedi sought to understand the reasons behind this non-adherence and discovered that traditional educational pamphlets were ineffective in improving medication adherence. Instead, she decided to explore a theater-based approach.

Trivedi’s research involves developing a culturally sensitive educational video for breast cancer patients, written by a local African American playwright in collaboration with the clinical team and input from African American survivors. Additionally, her team is testing the effectiveness of motivational interviewing, where pharmacy students personally engage with patients to address barriers to adherence and suggest solutions. Trivedi believes that these approaches, rooted in the humanities, will demonstrate their impact on health outcomes.

The role of humanities in team science

Recognizing the value of interdisciplinary collaboration, Trivedi incorporated the arts and humanities into her research by partnering with professors from the School of Theatre and Dance and the Valenti School of Communication at UH. This collaboration has highlighted the importance of incorporating arts into STEM fields, leading Trivedi to advocate for STEAM (Science, Technology, Engineering, Arts, and Mathematics).

Trivedi emphasizes that effective team science requires shared interest in the project, transparency, and honesty among team members. “We are a very efficient team working to achieve a common and important goal – to improve treatment outcomes and survival in patients.”

The Big Idea

Trivedi’s research underscores the role of social and cultural factors in medication adherence among specific patient groups. By posing her research question outside of her discipline, Trivedi engaged new collaborators who became invested in — and contributed directly to — positive health outcomes. This interdisciplinary approach, combining the insights of the humanities and the collaborative nature of team science, facilitated the development of novel solutions to enhance medication adherence.

------

This article originally appeared on the University of Houston's The Big Idea. Cory Thaxton, the author of this piece, is the communications coordinator for The Division of Research.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Nominations for the 2026 Houston Innovation Awards are due by Aug. 27

Calling All Innovators

Calling all Houston innovators: The 2026 Houston Innovation Awards, presented by InnovationMap, return this fall to celebrate the best and brightest in the Houston innovation ecosystem right now.

We're asking you to nominate Houston's top innovators and startups for this year's awards. Nominations are open now through August 27 and can be made on behalf of yourself, your organization, and other influential leaders in the local innovation scene.

The annual awards program recognizes the most innovative individuals and companies in Houston across 10 prestigious categories.

This year's awards will honor the following categories:

  • Minority-founded Business, honoring an innovative startup founded or co-founded by BIPOC or LGBTQ+ representation.
  • Female-founded Business, honoring an innovative startup founded or co-founded by a woman.
  • Energy Transition Business, honoring an innovative startup providing a solution within renewables, climatetech, clean energy, alternative materials, circular economy, and beyond.
  • Health Tech Business, honoring an innovative startup within the health and medical technology sectors.
  • Deep Tech Business, honoring an innovative startup providing technology solutions based on substantial scientific or engineering challenges, including those in the AI, robotics, and space sectors.
  • Startup of the Year (People's Choice), honoring a startup celebrating a recent milestone or success. The winner will be selected by the community via an interactive voting experience.
  • Scaleup of the Year, honoring an innovative later-stage startup that's recently reached a significant milestone in company growth.
  • Incubator/Accelerator of the Year, honoring a local incubator or accelerator that is championing and fueling the growth of Houston startups.
  • Mentor of the Year, honoring an individual who dedicates their time and expertise to guide and support budding entrepreneurs.
  • Trailblazer, honoring an innovator who's made a lasting impact on the Houston innovation community.

You have three weeks to submit nominees, so don't delay — nominate today at this link or fill out the form below. Qualified nominees will receive a formal application to complete, which will be reviewed by our esteemed panel of judges to determine the finalists and winners.

More announcements about the 2026 Houston Innovation Awards are coming soon, including an introduction to this year's panel of judges. Interested in sponsoring the 2026 Houston Innovation Awards? Please contact sales@innovationmap.com.

$5B Austin medical center, anchored by MD Anderson, to break ground this fall

moving forward

Construction on the $1 billion first phase of the AI-native University of Texas Dell Medical Center in Austin—which will feature a hospital operated by Houston’s UT MD Anderson Cancer Center—is set to start this fall.

The UT System Board of Regents approved funding for first-phase construction on Aug. 12.

The medical center—now expected to cost $5 billion, up from the initial $2.9 billion estimate—will span about 2.5 million square feet. It will include 300 to 500 patient beds, outpatient facilities, an emergency department and specialized care for cancer patients.

MD Anderson will bring its world-renowned oncology programs to the center’s integrated health care model, Dr. Claudia Lucchinetti, senior vice president of medical affairs at UT Austin and dean of the university’s Dell Medical School, tells Health Leaders.

Earlier this year, Austin tech billionaire Michael Dell and his wife, Susan, pledged $750 million for development of the medical center. The medical center, scheduled for completion in December 2030, will be a cornerstone of the new 300-acre UT Dell Campus for Advanced Research, a medical education and research hub.

“Through this new campus and medical center, Texas will lead America in health care innovation,” Gov. Greg Abbott said when the research campus was announced in April. “The next generation of medical breakthroughs will take place in Central Texas.”

The medical center will fold AI tools and other technology into the infrastructure, rather than having them added after it’s built. Among other capabilities, the technology will monitor real-time medical data, automate data entry, and help health care professionals quickly predict and identify risks to patients, according to Health Leaders.

“We are not just building a new medical center,” Lucchinetti says. “We are building a fundamentally new model of health. It’s not just a new facility. It’s not just a new collaboration. It is a convergence of capabilities that rarely come together at the same time.”